<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044821</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Replacing systemic with topical corticotherapy in patients with generalized bullous pemphigoid and serious steroidinduced iatrogenesis</dc:title>
<dc:description xml:lang="en">We describe four patients with generalized bullous pemphigoid, who received treatment with oral prednisone and suffered serious corticosteroid-induced iatrogenesis. In all cases, we decided to quickly withdraw the systemic corticosteroid treatment and begin treatment with 0.05 % clobetasol propionate (20 g/day). New outbreaks of pemphigoid or significant side effects were not seen after this change in medication. The topical treatment went on for five to twelve months, and the patients were followed up for extended periods after treatment ended, with no recurrences being observed. Systemic corticosteroid treatment may be replaced by topical treatment without complications, and this may be especially indicated in patients with serious corticosteroid-induced iatrogenesis</dc:description>
<dc:creator>García-Doval, Ignacio</dc:creator>
<dc:creator>Conde, Alberto</dc:creator>
<dc:creator>Mayo, Eugenia</dc:creator>
<dc:creator>Cruces, Manuel J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Describimos 4 pacientes con penfigoide ampolloso generalizado, que recibían tratamiento con prednisona oral y sufrieron iatrogenia corticoidea grave. En todos ellos optamos por realizar una retirada rápida del tratamiento corticoideo sistémico e iniciar tratamiento con propionato de clobetasol 0,05 % (20 g/día). Esta sustitución pudo hacerse sin observarse rebrotes del penfigoide ni efectos secundarios relevantes. El tratamiento tópico duró entre 5 y 12 meses y los pacientes han sido seguidos por periodos prolongados tras su finalización sin observarse recurrencias. La sustitución de terapéutica corticoidea sistémica a tópica puede hacerse sin complicaciones y podría estar especialmente indicada en los pacientes con iatrogenia grave por corticoides</dc:description>
<dc:source>Actas Dermosifiliogr;97(3): 186-188, abr. 2006. ilus</dc:source>
<dc:identifier>ibc-044821</dc:identifier>
<dc:title xml:lang="es">Sustitución de corticoterapia sistémica por tópica en pacientes con penfigoide ampolloso generalizado y iatrogenia esteroidea grave</dc:title>
<dc:subject>^d13642^s22020</dc:subject>
<dc:subject>^d7231^s22080</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29502^s22016</dc:subject>
<dc:subject>^d6082^s22073</dc:subject>
<dc:subject>^d29502^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d29502^s22012</dc:subject>
<dc:subject>^d29502^s22032</dc:subject>
<dc:subject>^d22622^s22073</dc:subject>
<dc:subject>^d29502^s22080</dc:subject>
<dc:subject>^d32747^s22074</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d32747^s22045</dc:subject>
<dc:subject>^d22389^s22073</dc:subject>
<dc:subject>^d13642^s28898</dc:subject>
<dc:type>article</dc:type>
<dc:date>200604</dc:date>
</metadata>
</record>
</ibecs-document>
